AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Cobankara, V Oran, B Ozatli, D Haznedaroglu, IC Kosar, A Buyukasik, Y Ozcebe, O Dundar, S Kirazli, S
Citation: V. Cobankara et al., Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis, CL APPL T-H, 7(2), 2001, pp. 126-130

Authors: Arslan, N Ozturk, E Ilgan, S Narin, Y Dundar, S Tufan, T Pekcan, M Bayhan, H
Citation: N. Arslan et al., The comparison of dual phase Tc-99m MIBI and Tc-99m MDP scintimammography in the evaluation of breast masses: Preliminary report, ANN NUCL M, 14(1), 2000, pp. 39-46

Authors: Dundar, S Ozcebe, OI
Citation: S. Dundar et Oi. Ozcebe, Behcet's disease and interferon: flaws in research integrity of randomisedtrial, LANCET, 356(9238), 2000, pp. 1351-1351

Authors: Demiroglu, H Ozcebe, OI Barista, I Dundar, S Eldem, B
Citation: H. Demiroglu et al., Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behcet's disease: a randomised trial, LANCET, 355(9204), 2000, pp. 605-609

Authors: Hisar, I Ileri, M Yetkin, E Atak, R Senen, K Kosar, F Dundar, S Demirkan, D
Citation: I. Hisar et al., Role of activated protein C resistance in left atrial thrombogenesis in patients with mitral stenosis, ANGIOLOGY, 51(10), 2000, pp. 855-860

Authors: Guven, D Sayinalp, N Kalayci, D Dundar, S Hasiripi, H
Citation: D. Guven et al., Risk factors in central retinal vein occlusion and activated protein C resistance, EUR J OPTHA, 9(1), 1999, pp. 43-48

Authors: Bas, B Koksal, A Ozatli, D Haznedaroglu, I Kosar, A Buyukasik, Y Ozcebe, O Dundar, S
Citation: B. Bas et al., Thrombosis and hemorrhage in chronic myeloproliferative disorders, CL APPL T-H, 5(4), 1999, pp. 282-284

Authors: Kosar, A Haznedaroglu, S Karaaslan, Y Buyukasik, Y Haznedaroglu, IC Ozath, D Sayinalp, N Ozcebe, O Kirazli, S Dundar, S
Citation: A. Kosar et al., Effects of interferon-alpha 2a treatment on serum levels of tumor necrosisfactor-alpha, tumor necrosis factor-alpha 2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease, RHEUM INTL, 19(1-2), 1999, pp. 11-14

Authors: Haznedaroglu, IC Buyukasik, Y Kosar, A Ozcebe, OI Kirazli, S Dundar, S
Citation: Ic. Haznedaroglu et al., Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura, ACT HAEMAT, 101(1), 1999, pp. 16-20

Authors: Kosar, A Haznedaroglu, IC Buyukasik, Y Ozcebe, O Kirazli, S Dundar, S
Citation: A. Kosar et al., Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmuneversus aplastic thrombocytopenia, HAEMATOLOG, 83(11), 1998, pp. 1055-1056

Authors: Demiroglu, H Yalcin, S Buyukasik, Y Ozcebe, OI Dundar, S
Citation: H. Demiroglu et al., Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behcet's disease: a prospective study, ANN RHEUM D, 57(11), 1998, pp. 694-696
Risultati: 1-11 |